These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC, Mendoza MM, Yahr MD. Adv Biochem Psychopharmacol; 1980 Mar; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
13. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Gawel M, Riopelle R, Libman I, Bouchard S. Adv Neurol; 1987 Mar; 45():535-8. PubMed ID: 3548263 [No Abstract] [Full Text] [Related]
14. [Therapy of Parkinson's disease. Practical criteria of treatment]. Casacchia M, Carolei A, Zamponi A, Agnoli A, Fazio C. Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360 [No Abstract] [Full Text] [Related]
16. [Treatment of parkinsonism]. Kaste M, Iivanainen M. Duodecim; 1976 Nov; 92(10):514-25. PubMed ID: 949943 [No Abstract] [Full Text] [Related]
17. The drug treatment of Parkinson's disease. Morris JG. Aust Fam Physician; 1984 May; 13(5 Suppl):6-8, 11. PubMed ID: 6497767 [Abstract] [Full Text] [Related]
18. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [Abstract] [Full Text] [Related]
19. [Therapy of tparkinson's disease. Clinical and pharmacological viewpoints]. Przuntek H. Med Klin; 1979 Jul 13; 74(28-29):1077-83. PubMed ID: 39230 [No Abstract] [Full Text] [Related]
20. How to achieve maximum benefit for the patient with Parkinson's disease. Greer M. Geriatrics; 1976 Apr 13; 31(4):89-96. PubMed ID: 4356 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]